Intrinsic Value of S&P & Nasdaq Contact Us

Biodexa Pharmaceuticals Plc BDRX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • GB • USD

SharesGrow Score
27/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Over the last 12 months, insiders have made 6 transactions in BDRX stock — 0 buys (valued at RSU Award) and 0 sells (valued at RSU Award).

BDRX Insider Ownership

Top Holder
-
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Buy 0%
Sell 0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-03-18 Parker Stephen Barry Director Unknown 576 $475.00 $273.6K
2026-03-18 De Vries Simon Director Unknown 288 $475.00 $136.8K
2026-03-18 Merchant Ann Louise Director Unknown 288 $475.00 $136.8K
2026-03-18 Powell Fiona Mary Chief Financial Officer Unknown 8,750 $7.41 $64.84K
2026-03-18 Stamp Stephen Anthony Chief Executive Officer Unknown 15,000 $5.40 $81K
2026-03-18 Turton Simon Director Unknown 288 $475.00 $136.8K
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message